Abbott Says Withdrawing Attention Deficit Drug (Reuters)
Reuters - Abbott Laboratories Inc. said
Thursday it was halting sales of a 30-year-old attention
deficit drug that a consumer group complained was too dangerous
to stay on the market.
Read more...